Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $4.65 Million - $4.88 Million
-29,956 Reduced 90.88%
3,006 $475,000
Q4 2023

Feb 13, 2024

BUY
$145.6 - $158.88 $959,940 - $1.05 Million
6,593 Added 25.0%
32,962 $5.17 Million
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $4.11 Million - $4.6 Million
26,369 New
26,369 $4.11 Million
Q1 2023

May 12, 2023

BUY
$151.05 - $180.26 $3.46 Million - $4.12 Million
22,876 Added 139.67%
39,255 $6.08 Million
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $2.62 Million - $2.94 Million
16,379 New
16,379 $2.89 Million
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $1.59 Million - $1.76 Million
-9,447 Reduced 88.03%
1,284 $228,000
Q1 2022

May 13, 2022

SELL
$158.14 - $179.59 $451,489 - $512,729
-2,855 Reduced 21.01%
10,731 $1.9 Million
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $2.12 Million - $2.35 Million
13,586 New
13,586 $2.32 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $2.11 Million - $2.35 Million
-13,079 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $2.09 Million - $2.24 Million
13,079 New
13,079 $2.16 Million
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $2.54 Million - $2.79 Million
-18,123 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$128.81 - $155.51 $1.64 Million - $1.97 Million
12,694 Added 233.82%
18,123 $2.55 Million
Q1 2020

May 06, 2020

SELL
$111.14 - $153.99 $127,144 - $176,164
-1,144 Reduced 17.4%
5,429 $712,000
Q4 2019

Feb 12, 2020

BUY
$127.5 - $146.44 $764,362 - $877,907
5,995 Added 1037.2%
6,573 $959,000
Q3 2019

Nov 08, 2019

SELL
$126.95 - $142.14 $40,877 - $45,769
-322 Reduced 35.78%
578 $75,000
Q2 2019

Aug 12, 2019

BUY
$131.15 - $144.24 $118,035 - $129,816
900 New
900 $125,000
Q1 2019

May 02, 2019

SELL
$125.72 - $139.79 $9,177 - $10,204
-73 Closed
0 $0
Q4 2018

Feb 08, 2019

BUY
$122.84 - $147.84 $8,967 - $10,792
73 New
73 $9,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Pearl River Capital, LLC Portfolio

Follow Pearl River Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pearl River Capital, LLC with notifications on news.